NIROGACESTAT for Soft tissue neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 40 adverse event reports in the FDA FAERS database where NIROGACESTAT was used for Soft tissue neoplasm.
Most Reported Side Effects for NIROGACESTAT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 220 | 44.3% | 1 | 13 |
| Nausea | 136 | 27.4% | 0 | 12 |
| Fatigue | 110 | 22.1% | 0 | 6 |
| Headache | 62 | 12.5% | 0 | 4 |
| Product dose omission issue | 60 | 12.1% | 0 | 4 |
| Rash | 59 | 11.9% | 0 | 8 |
| Vomiting | 50 | 10.1% | 0 | 8 |
| Stomatitis | 42 | 8.5% | 1 | 5 |
| Product dose omission in error | 34 | 6.8% | 0 | 2 |
| Cough | 33 | 6.6% | 0 | 3 |
| Pruritus | 31 | 6.2% | 0 | 2 |
| Intentional underdose | 30 | 6.0% | 0 | 4 |
| Alopecia | 28 | 5.6% | 0 | 2 |
| Abdominal discomfort | 25 | 5.0% | 0 | 0 |
| Hot flush | 23 | 4.6% | 0 | 0 |
Other Indications for NIROGACESTAT
Product used for unknown indication (263)
Desmoid tumour (158)
Connective tissue neoplasm (39)
Plasma cell myeloma (20)
Plasma cell myeloma refractory (11)
Other Drugs Used for Soft tissue neoplasm
PEXIDARTINIB (223)
PAZOPANIB (85)
VIMSELTINIB (64)
IMATINIB (24)
NIVOLUMAB (20)
CABOZANTINIB S-MALATE (17)
SORAFENIB (14)
SUNITINIB MALATE (14)
CABOZANTINIB (12)
IFOSFAMIDE (11)